Title
Category
Credits
Event date
Cost
Antimicrobial Stewardship 101
  • Antimicrobial Stewardship
  • 0.25 AMA PRA Category 1 Credit™
$0.00
Opioid Use Disorder: Identifying Patients at Risk and Developing Management Plans
  • Opioid Use Disorder (OUD)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
$0.00
Patients and health care professionals (HCPs) face additional challenges when the treatments prescribed for pain management (e.g., opioids) lead to substance use problems. HCPs must then re-evaluate treatment plans for acute, subacute, and chronic pain and encourage treatment for opioid use disorder (OUD). There are strategies available to HCPs to help identify patients at risk for OUD, most notably found in the 2022 CDC Guideline for Prescribing Opioids, which could help prevent OUD in patients through screening and identifying alternate treatments.
Mandated Reporter Training: Identifying and Reporting Child Abuse and Maltreatment
  • State Mandated Training
  • Mandated Reporter
  • 2.00 Participation
$0.00
Mandated reporters can participate in this 2-hour web-based online training course at any time, 24/7. Users must complete the course within the course duration which is the current calendar year. Progress is saved at the end of each section, so you can complete it at your own pace. Please be advised that the Office of Children and Family Services now requires all mandated reporters to take a short multiple choice test both before and after the mandated reporter training.
Embracing the Journey: End of Life and Palliative Care
  • Palliative Care
  • End of Life Care
  • 1.00 AANP Contact Hours
  • 0.75 AANP Pharmacology Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
$0.00
All seriously ill patients can benefit from palliative care principles in the primary care setting. This session is designed to offer clinicians the information and skills needed to provide high-quality primary palliative care to patients with serious illness. Participants will develop a toolbox of palliative care competencies including pain and symptom management and serious illness communication skills.
Suicide Prevention: Evidence into Practice
  • Suicide
  • 1.00 AMA PRA Category 1 Credit™
$0.00
Suicide was declared a public health crisis by the U.S. Surgeon General in 1999. However, suicide rates continued to climb over the past two decades by a staggering 35% (1999-2018). Fortunately, we have seen decreases in the national suicide rates from 2018-2020. The pandemic’s impact on mental health is a major focus of public health concern and while distress and mental health suffering have increased, the suicide rate in the US actually decreased by 3% from 2019 to 2020.
Utah Controlled Substance Database and Proper Opioid Prescribing Training
  • State Mandated Training
  • 0.50 Participation
$0.00
This video covers an introduction and description of the Utah Controlled Substance Database, Utah CSD act, law and regulations, CSD account creation, patient and prescriber dashboards, proxy information and medication disposal.This training fulfills 0.5 hours towards the Controlled Substance Training CE requirement of Utah Code §58-37-6.5.
Counseling to Access to Lethal Means (CALM) to Prevent Suicide
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASWB
$0.00
An Online Training by CALM Produced by Intermountain Health for Colorado, Idaho, Kansas, Montana, Nevada, Utah, and Wyoming. 
Early Detection and Diagnosis of Mild Cognitive Impairment and Alzheimers Disease
  • Cognitive Impairment
  • 0.58 AANP Contact Hours
  • 0.50 AMA PRA Category 1 Credit™
$0.00
In the context of a patient case presentation, expert faculty will highlight the stages of Alzheimer disease (AD) and the vital importance of early detection of mild cognitive impairment (MCI). They will discuss screening for MCI and current guidelines and standards of care for establishing a diagnosis of AD. The faculty will also examine the effects of increasingly more accessible neuroimaging and fluid markers on the diagnosis of AD, especially with the recent FDA approvals of anti-amyloid therapies.
Mind Over Memory: New Treatment Options for Alzheimer Disease
  • Alzheimer’s Disease
  • Cognitive Impairment
  • Pharmacology
  • 0.48 AANP Contact Hours
  • 0.48 AANP Pharmacology Contact Hours
  • 0.50 AMA PRA Category 1 Credit™
$0.00
Embark on a captivating journey with our distinguished neurology faculty as they delve into the revolutionary world of FDA-approved monoclonal antibody therapies targeting β-amyloid in the treatment of Alzheimer disease (AD). Uncover clinical efficacy, safety nuances, and differences between these newer disease-modifying agents compared to older medications used for AD.
Mind Over Memory: Strategies for Increasing Early Identification of Alzheimer Disease from a Dementia Specialist
  • Alzheimer’s Disease
  • Cognitive Impairment
  • 0.48 AANP Contact Hours
  • 0.50 AMA PRA Category 1 Credit™
$0.00
In this podcast, expert faculty bring you insights from the evolving area of Alzheimer disease diagnosis, including strategies for improving identification of cognitive decline and incorporating evidence-based tools in screening. Discover the impact of advanced neuroimaging and fluid markers, empowered by recent FDA approvals of anti-amyloid therapies. Come away with actionable knowledge to boost your role in cognitive health. 

Pages